Compositions comprising HDAC inhibitors and methods of their use in restoring stem cell function and preventing heart failure

Details for Australian Patent Application No. 2008333972 (hide)

Owner New York Medical College

Inventors Kajstura, Jan; Anversa, Piero; Leri, Annarosa

Agent Pizzeys

Pub. Number AU-A-2008333972

PCT Pub. Number WO2009/073618

Priority 60/991,663 30.11.07 US

Filing date 1 December 2008

Wipo publication date 11 June 2009

International Classifications

C12N 5/07 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells or tissues

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

22 July 2010 PCT application entered the National Phase

  PCT publication WO2009/073618 Priority application(s): WO2009/073618

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008333985-Antibodies to the PcrV antigen of pseudomonas aeruginosa

2008333953-Kit and method for detecting bovine viral diarrhea virus in tissue samples